Skip to main content

Table 1 Preoperative characteristics of patients with and without concomitant tricuspid annuloplasty

From: Impact of concomitant tricuspid annuloplasty on right ventricular remodeling in patients with rheumatic mitral valve disease

Variables

TAP group (n = 124)

Non-TAP group (n = 46)

P value

Age, y

53.0 (47.0, 62.0)

50.0 (44.0, 59.0)

0.03

Female

98 (79%)

33 (72%)

0.32

Body surface area, m2

1.53 (1.45, 1.62)

1.59 (1.49, 1.66)

0.04

NYHA functional class III-IV

92 (74%)

22 (48%)

0.001

Atrial fibrillation

99 (80%)

16 (35%)

<  0.001

Echocardiographic data

 LV end-diastolic volume, ml

102.0 (86.3, 127.8)

100.5 (88.8, 120.0)

0.99

 LV ejection fraction, %

61.0 (54.0, 66.0)

67.0 (60.0, 68.3)

<  0.001

 Left atrial volume, ml

135.0 (99.0, 173.0)

119.5 (89.2, 138.0)

0.03

 Right atrial volume, ml

51.1 (39.7, 67.0)

33.5 (25.8, 44.0)

<  0.001

TR grade

 None to trace

3 (3%)

17 (37%)

<  0.001

 Mild

29 (23%)

29 (63%)

<  0.001

 Moderate

57 (46%)

0

<  0.001

 Severe

35 (28%)

0

<  0.001

TV annulus diameter, mm

34.0 (31.0, 36.8)

28.0 (27.0, 31.0)

<  0.001

Indexed TV annulus diameter, mm/m2

22.3 (20.6, 23.8)

18.2 (17.2, 19.6)

<  0.001

Pulmonary artery systolic pressure, mmHg

38.6 (33.0, 47.8)

29.8 (24.4, 38.0)

<  0.001

 RV inlet dimension, mm

36.3 (32.9, 39.3)

32.9 (31.3, 37.0)

<  0.001

 TAPSE, mm

11.9 (9.1, 15.2)

14.4 (10.4, 17.4)

0.01

 RV fractional area change, %

40.2 (34.0, 44.9)

41.7 (36.0, 47.8)

0.09

 Tissue Doppler of the tricuspid annulus, cm/s

9.2 (7.9, 10.7)

9.7 (8.2, 11.8)

0.15

 RV end-diastolic volume, ml

51.3 (43.4, 64.6)

41.3 (35.8, 46.1)

<  0.001

 RV ejection fraction, %

32.6 (28.6, 35.2)

40.9 (36.6, 46.1)

<  0.001

 RVLS of free wall, %

−15.5 (−18.6, −13.4)

−22.0 (−24.3, −18.7)

<  0.001

 RVLS of septal wall, %

−10.2 (−11.9, −8.6)

−12.3 (− 13.7, −10.9)

<  0.001

Operative data

 Concomitant MAZE procedures

59 (48%)

2 (4%)

<  0.001

 Mechanical mitral prosthesis

94 (76%)

39 (85%)

0.21

 Cardiopulmonary bypass time, min

100.0 (84.0, 126.8)

78.5 (66.8, 99.2)

<  0.001

 MV lesion

  Stenosis

79 (64%)

34 (74%)

0.21

  Regurgitation

17 (14%)

6 (13%)

0.91

  Mixed

28 (23%)

6 (13%)

0.17

  1. LV left ventricle, MV mitral valve, NYHA New York Heart Association, RV right ventricle, RVLS right ventricular longitudinal strain, TAP tricuspid annuloplasty, TAPSE tricuspid annular plane systolic excursion, TR tricuspid regurgitation, TV tricuspid valve
  2. Data are expressed as median (interquartile range) or n (%)